May 4, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: | Lexaria Bioscience Corp. |
| Registration Statement on Form S-1, as amended |
| File No. 333-271096 |
Ladies and Gentlemen:
As the underwriter of the proposed offering of Lexaria Biosciences. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated May 3, 2023 for the above-referenced Registration Statement.
| Very truly yours, |
| |
|
|
| |
| Maxim Group LLC |
| |
|
|
| |
By: | /s/ Clifford A. Teller |
| |
| Name: Clifford A. Teller |
| |
| Title: Co-President |
| |
